中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
Author:(Weineng FENG)

1.NRP1 expression is associated with chemosensitivity and poor prognosis in advanced non-small cell lung cancer patients treated with ifrst-line platinum-based chemotherapy

Weineng FENG ; Liangyun ZHANG ; Haiyan SHI ; Zecheng CHEN ; Yicong TANG ; Yanming DENG

China Oncology 2016;26(6):514-520

2.Study on Relationship Between Chinese Budd-Chiari Syndrome and Factor Ⅴ Leiden Mutation

Bo FENG ; Ke XU ; Hong JIANG ; Chunyuan JIN ; Weineng FU ; Fucai LI ; Hong LI ; Hongying SU ; Xitong ZHANG

Journal of China Medical University 2001;30(1):53-55

3.The preliminary results of a phase II randomized clinical trial of high-dose toremifene chemosensitization in stage IIIB/IV non-small cell lung cancer.

Hua CHENG ; Yilong WU ; Lijia GU ; Weineng FENG ; Yimin WENG ; Chao CHENG ; Wenzhao ZHONG ; Shaohong HUANG

Chinese Journal of Lung Cancer 2003;6(5):335-338

4.EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-mutated NSCLC: A Prospective, Randomized, Exploratory Study

Weiguang GU ; Hua ZHANG ; Yiyu LU ; Minjing LI ; Shuang YANG ; Jianmiao LIANG ; Zhijian YE ; Zhihua LI ; Minhong HE ; Xiaoliang SHI ; Fei WANG ; Dong YOU ; Weiquan GU ; Weineng FENG

Cancer Research and Treatment 2023;55(3):841-850

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO